Terug
Dagbereik
€ 1,86
€ 2,00
52-Weeksbereik
€ 0,46
€ 7,13
Volume
804.092
50D / 200D Gem.
€ 2,16
/
€ 2,35
Vorige Slotkoers
€ 1,93
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,7 | 0,4 |
| P/B | 1,9 | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | -16977,8 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 4,67
+140.7%
Low: € 3,00
High: € 6,00
Forward WPA
-€ 0,71
Omzet Sch.
300000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,11
€ 0,11 – € 0,11
|
330 M | 1 |
| FY2029 |
-€ 0,26
-€ 0,26 – -€ 0,26
|
130 M | 1 |
| FY2028 |
-€ 0,39
-€ 0,44 – -€ 0,33
|
60 M | 2 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -135,31M
PEG of 0,11 suggests growth is underpriced
Capital intensive — 1701,68% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)1075,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-40,74%
Net Margin-16977,83%
Op. Margin-18477,83%
Veiligheid
Debt / Equity
0,01
Current Ratio9,13
Interest Coverage-41251,75
Waardering
P/E Ratio
-3,70
P/B Ratio1,87
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1075,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 893.000,0 | Net Income (TTM) | -151,61M |
| ROE | N/A | ROA | -45,18% |
| Gross Margin | -540,76% | Operating Margin | -18477,83% |
| Net Margin | -16977,83% | Free Cash Flow (TTM) | -135,31M |
| ROIC | -40,74% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 9,13 |
| Interest Coverage | -41251,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,70 | P/B Ratio | 1,87 |
| P/S Ratio | 628,96 | PEG Ratio | 0,11 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 561,66M | Enterprise Value | 456,09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 893.000,0 | 76.000,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -151,61M | -61,19M | -35,47M | -108,03M | -55,15M |
| EPS (Diluted) | -0,51 | -0,62 | -0,57 | -1,76 | -1,73 |
| Gross Profit | -4,83M | 76.000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -165,01M | -183,68M | -151,52M | -153,01M | -55,11M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 335,57M | 441,07M | 420,55M | 518,00M | 40,30M |
| Total Liabilities | 34,78M | 39,44M | 29,22M | 13,06M | 13,38M |
| Shareholders' Equity | 300,79M | -994,95M | -1,10B | -1,10B | 26,92M |
| Total Debt | 2,97M | 3,24M | 4,41M | 2,40M | 1,33M |
| Cash & Equivalents | 108,54M | 99,12M | 60,65M | 490,25M | 20,56M |
| Current Assets | 280,68M | 395,88M | 374,15M | 504,72M | 27,27M |
| Current Liabilities | 30,74M | 36,22M | 25,04M | 10,87M | 12,31M |